financetom
Business
financetom
/
Business
/
Relief for Alembic Pharma, United Phosphorous: SC sets aside NGT Order, rules against closure of Gujarat facilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Relief for Alembic Pharma, United Phosphorous: SC sets aside NGT Order, rules against closure of Gujarat facilities
Apr 3, 2020 1:22 AM

In a big relief for BSE listed Alembic Pharma and United Phosphorous, the Supreme Court of India (SC) has set aside a 2016 National Green Tribunal (NGT) order that had directed the closure of their facilities in Gujarat.

In January of 2016, the NGT had passed an order directing for revocation of the Environment Clearance and closure of the industrial units of Alembic Pharma and United Phosphorous. The NGT had passed orders for closure, after it had held that grant of ex-post-facto Environmental Clearance under the Ministry of Environment and Forests Circular of May 2002, was not sound in law.

A bench of SC headed by Justice DY Chandrachud, in its judgment noted, "Alembic Pharma, United Phosphorous operated for many years in Ankleshwar-Guj without the Environment Clearance." The Court also observed in the judgment, "Court cannot be oblivious to the environmental degradation caused by all three industries units that operated without valid ECs." The judgment also held that this was a clear case of companies having evaded the legally binding regime of obtaining ECs, cannot escape the liability.

However, interestingly, Justice DY Chandchud headed bench also reasoned, "Industrial units have made infrastructural investments and employed significant numbers of workers in their facilities." SC judgment held, "Court needs to take a balanced approach in light of economic interests, NGT directions for closure are not in keeping with principles of proportionality."

Stressing on the need for balance and proportionality, the SC held that NGT directing closure of industrial units was not warranted and consequently, set aside the NGT directions for bringing down the shutters.

However, as a rap on the knuckles, SC noted that penalties must be imposed for disobedience with a binding legal regime. SC has, therefore, directed for a levy of penalty of 10 cr on each of the errant companies. SC has directed the penalty amount to be used for the purpose of restitution and restoration of the environment. SC has also specified that the penalty amount to be deposited within 4 months of the judgment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jazz Pharmaceuticals Q3 revenue beats estimates
Jazz Pharmaceuticals Q3 revenue beats estimates
Nov 5, 2025
Overview * Jazz Pharmaceuticals ( JAZZ ) Q3 revenue grows 7% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting robust operational performance * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln Outlook * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln * Jazz Pharmaceuticals ( JAZZ ) expects top-line data from zanidatamab...
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Nov 5, 2025
Overview * Cytokinetics ( CYTK ) Q3 net loss widens to $306.2 mln, driven by debt conversion expense * Company reports Q3 revenue of $1.9 mln, up from $0.5 mln last year * Cytokinetics ( CYTK ) prepares for potential U.S. launch of aficamten pending FDA approval Outlook * Company expects EMA decision on aficamten MAA in 1H 2026 *...
Delaware judge says she will not block Metsera from ending Pfizer deal 
Delaware judge says she will not block Metsera from ending Pfizer deal 
Nov 5, 2025
WILMINGTON, Delaware, Nov 5 (Reuters) - A Delaware judge said on Wednesday she would reject a request by Pfizer ( PFE ) to temporarily block Metsera ( MTSR ) from terminating its takeover deal with Pfizer ( PFE ), allowing Metsera ( MTSR ) to proceed instead with a higher $10 billion deal from Novo Nordisk. ...
World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business
World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business
Nov 5, 2025
MIAMI--(BUSINESS WIRE)-- World Kinect Corporation ( WKC ) today announced that it has completed its previously announced acquisition of the Trip Support Services (TSS) division of Universal Weather and Aviation. Universal Weather, headquartered in Houston, Texas, has been a pioneer in trip support services with deep expertise in international travel regulations, logistics, and supply chain management. Its trip support business...
Copyright 2023-2026 - www.financetom.com All Rights Reserved